Nab-Paclitaxel Plus Gemcitabine Vs Gemcitabine Alone for Patients with Metastatic Pancreatic Cancer: Influence of Primary Pancreatic Tumor Location on Efficacy and Treatment Exposure in the Mpact Phase III Trial

Autor:	Ferrara Stefano, Stahl Michael, Lopez-Martin Jose, Nugent Francis, Penenberg Darryl, Balcke Peter, Karapetis Christos, Milella Michele, Ma Wen Wee, Lu Brian, Kennecke Hagan, Von Hoff Daniel, Prager Diane
Rok vydání:	2014
Předmět:	Oncology medicine.medical_specialty business.industry Hematology medicine.disease Gemcitabine chemistry.chemical_compound Paclitaxel chemistry Paclitaxel protein-bound Pancreatic tumor Internal medicine Pancreatic cancer Metastatic pancreatic cancer medicine CA19-9 business Stage iv medicine.drug
Zdroj:	Annals of Oncology. 25:ii21
ISSN:	0923-7534
DOI:	10.1093/annonc/mdu165.26
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7cdc2b6c04b1413a74ab4c8171ed6c93 https://doi.org/10.1093/annonc/mdu165.26 Zobrazit plný text záznamu